KNX100 / Kinoxis Therapeutics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KNX100 / Kinoxis Therapeutics
KTX101, NCT04901078: A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers

Completed
1
64
RoW
KNX100, KNX100 placebo
Kinoxis Therapeutics Pty Ltd, National Institute on Drug Abuse (NIDA)
Healthy Volunteer Study, Opioid-use Disorder
09/23
09/23

Download Options